You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lenvatinib

Showing 26 - 50 of 247
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Lenvatinib
  • +2 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 20, 2022

Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous NSCLC, Metastatic Non-squamous Non Small Cell Lung

Not yet recruiting
  • Advanced Non-squamous Non-small-cell Lung Cancer
  • +2 more
  • Beijing, Beijing, China
    Peking University First Hospital Ethics Committee
Sep 10, 2023

Hepatocellular Carcinoma Trial (Oncorine, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Jan 30, 2023

Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • Lenvatinib
  • +2 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Feb 7, 2023

Melanoma Trial in Shanghai (Tislelizumab, Lenvatinib, Cryoablation)

Recruiting
  • Melanoma
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 8, 2022

Prostate Cancer Metastatic, Neuroendocrine Tumors Trial in Atlanta, Ann Arbor (Pembrolizumab, Lenvatinib)

Recruiting
  • Prostate Cancer Metastatic
  • Neuroendocrine Tumors
  • Duarte, California
  • +2 more
Jan 18, 2023

Mesotheliomas Pleural Trial in Amsterdam (Pembrolizumab, Lenvatinib)

Recruiting
  • Mesotheliomas Pleural
  • Amsterdam, Noord-Holland, Netherlands
    Antoni van Leeuwenhoekziekenhuis (NKI-AVL)
Jan 13, 2023

Hepatocellular Carcinoma Non-resectable Trial in France (Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Lenvatinib
  • Bordeaux, France
  • +5 more
Jun 12, 2023

Neuroendocrine Tumors, Well-Differentiated Neuroendocrine Carcinoma, High Grade Neuroendocrine Carcinoma, Any Site Trial in San

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Lenvatinib
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Feb 17, 2023

Mucosal Melanoma Trial in Wollstonecraft (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Mucosal Melanoma
  • Wollstonecraft, New South Wales, Australia
    Melanoma Institute Australia
Sep 15, 2022

Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)

Active, not recruiting
  • Leiomyosarcoma
  • +3 more
  • Taipei, Taiwan
  • +1 more
Dec 27, 2022

Recurrent Endometrial Carcinoma, Unresectable Endometrial Carcinoma Trial in Miami (Lenvatinib, Pembrolizumab, Hypofractionated

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • Unresectable Endometrial Carcinoma
  • Lenvatinib
  • +2 more
  • Miami, Florida
    University of Miami
Jan 10, 2023

Hepatocellular Carcinoma Trial in Beijing (Sintilimab, Lenvatinib, radiotherapy)

Recruiting
  • Hepatocellular Carcinoma
  • Beijing, Beijing, China
    Beijing Tsinghua Changgung Hospital
Jan 5, 2023

Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

Not yet recruiting
  • Untreated Advanced or Recurrent Thymic Carcinomas
  • Chuo, Tokyo, Japan
    National Cancer Center Hospital
Apr 16, 2023

Liver Metastasis Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)

Recruiting
  • Liver Metastasis
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 8, 2022

Carcinoma, Renal Cell Trial in China (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +3 more
  • Beijing, Beijing, China
  • +16 more
Jun 2, 2023

Advanced Hepatocellular Carcinoma Trial in Shanghai (Tislelizumab, lenvatinib, US/CT-guided Percutaneous Cryoablation)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 8, 2022

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Sintilimab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Nov 10, 2022

Hepatocellular Carcinoma Trial in Shanghai (lenvatinib, TACE)

Active, not recruiting
  • Hepatocellular Carcinoma
  • lenvatinib
  • TACE
  • Shanghai, China
    Huashan hospital
Jul 29, 2022

Tumor, Adenocarcinoma Trial in Houston (Pembrolizumab, lenvatinib)

Recruiting
  • Tumor
  • Adenocarcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Oct 13, 2022

Metastatic Breast Cancer Trial in United States (Lenvatinib, Pembrolizuma, Fulvestrant)

Not yet recruiting
  • Metastatic Breast Cancer
  • Lenvatinib
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Oct 31, 2023

Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)

Recruiting
  • Melanoma Stage III
  • North Sydney, New South Wales, Australia
    Melanoma Institute Australia
Oct 26, 2022

Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in Rochester

Completed
Has Results
  • Malignant Adrenal Gland Pheochromocytoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 28, 2022

Hepatocellular Carcinoma Trial in Guangzhou (TACE(Transcatheter arterial chemoembolization), Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • TACE(Transcatheter arterial chemoembolization)
  • Lenvatinib
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
May 17, 2022

Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)

Recruiting
  • Advanced Biliary Tract Cancer
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 11, 2022